Abstract 128 Table 1

Demographics of patients undergoing Cardiac Transplant. (n = 243)

Non-Cardiac SarcoidCardiac sarcoid
No of participants236 (97%)7 (3%)
Age41 +- 1550 +- 9
Gender Male Female165 (70%)78 (30%)7 (100%)0 (0%)
Current Status Alive Dead167 (70%)69 (30%)5 (71%)2 (29%)
Diagnostic tests (needed to confirm diagnosis)--------6 (86%)
 CMR/FDG-PET scans Endomyocardial biopsy----------------1 (14%)7 (100%)
Sarcoidosis on explanted heart histology
Sarcoidosis types
 Cardio-pulmonary sarcoidosis Multisystem sarcoidosis Isolated cardiac sarcoidosis------------------------3 (43%)1 (14%)3 (43%)
Implanted cardiac device types (pre-transplant)
 ICD/ CRT-D CRT-P None------------------------5 (71%)1 (14%)1 (14%)
Post-Transplant immunosuppressive regimen
 Tacrolimus/Sirolimus Mycophenolate Mofetil (MMF) Prednisolone (both patients with CS relapse in transplanted heart were on maintenance dose 3-5mg OD)---------------- --------5/5 (100%)5/5 (100%)3/5 (60%)
  • Continuous variables are presented as numbers and percentages and categorical variables are presented as mean +- standard deviation